Literature DB >> 1494499

Microvascular effects of atrial natriuretic peptide in rat cremaster.

R W Barbee1, L M Harrison-Bernard, P K Carmines.   

Abstract

Experiments utilized the open cremaster preparation to test the hypothesis that atrial natriuretic peptide (ANP)-induced volume changes result from microvascular resistance alterations. Atrial natriuretic peptide (25, 100, and 500 ng/kg/min, IV) or vehicle was infused into anesthetized rats. At the two highest ANP infusion rates, mean arterial pressure was significantly reduced from 104 +/- 3 (control) to 87 +/- 2 and 77 +/- 2 mmHg, respectively. Hematocrit was 41.0 +/- 0.8 and 45.6 +/- 0.9% (p < 0.05) at the end of vehicle and ANP infusions, respectively. Despite these effects of ANP, there were no significant arteriolar or venular diameter alterations. Thirty microM nitroprusside significantly dilated all vessel segments except large venules. These observations suggest that resistance alterations in the skeletal muscle microvasculature are not the cause of ANP-induced fluid movement.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1494499     DOI: 10.1016/0196-9781(92)90026-y

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  4 in total

1.  Effect of endopeptidase-24.11 inhibitors and C-ANP receptor ligand on responses evoked in arterioles of rat cremaster muscle by atrial natriuretic peptide.

Authors:  J Peyroux; F Beslot; N Claperon; M C Fournie-Zaluski; B P Roques
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

2.  Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure.

Authors:  Rita Holtwick; Michael Gotthardt; Boris Skryabin; Martin Steinmetz; Regine Potthast; Bernd Zetsche; Robert E Hammer; Joachim Herz; Michaela Kuhn
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

3.  Regulatable atrial natriuretic peptide gene therapy for hypertension.

Authors:  Kurt J Schillinger; Sophia Y Tsai; George E Taffet; Anilkumar K Reddy; Ali J Marian; Mark L Entman; Kazuhiro Oka; Lawrence Chan; Bert W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-14       Impact factor: 11.205

4.  Atrial natriuretic peptide attenuates flow in an isolated lymph duct preparation.

Authors:  D J Atchison; M G Johnston
Journal:  Pflugers Arch       Date:  1996-02       Impact factor: 3.657

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.